Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
12/08/2026 12:34
BRIEF-Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates Aug 12 (Reuters) - Xilio Therapeutics Inc XLO.O:
XILIO THERAPEUTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES PIPELINE AND BUSINESS UPDATES
XILIO THERAPEUTICS - PLANS TO REPORT INITIAL PHASE 1 DATA IN PATIENTS WITH METASTATIC NSCLC IN H2 2027
XILIO THERAPEUTICS - EXPECTS CASH RUNWAY INTO Q1 2028
Source text: ID:nGNX8ZCxXg
Further company coverage: XLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla